BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1482 related articles for article (PubMed ID: 26235541)

  • 1. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
    Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D
    Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
    Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis.
    Wang Z; Zhao H; Wang X; Zhang H; Jiang M; Tsauo J; Luo X; Yang L; Li X
    Abdom Imaging; 2015 Aug; 40(6):1813-20. PubMed ID: 25504374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
    Wu W; Zhang H; Zeng Z; Wang X; Kong D
    Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding.
    Sun XY; Wang GC; Wang J; Huang GJ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2021 Apr; 20(2):128-136. PubMed ID: 33455864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
    Merola J; Fortune BE; Deng Y; Ciarleglio M; Amirbekian S; Chaudhary N; Shanbhogue A; Ayyagari R; Rodriguez-Davalos MI; Teperman L; Charles HW; Sigal SH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
    D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
    Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Mukund A; Marri UK; Jindal A; Choudhury A; Patidar Y; Sarin SK
    Dig Dis Sci; 2023 Jul; 68(7):3174-3184. PubMed ID: 37169934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant).
    Wan YM; Li YH; Wu HM; Xu ZY; Xu Y; Yang LH; Wu XN; Yang JH
    Medicine (Baltimore); 2017 Nov; 96(45):e8498. PubMed ID: 29137043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.